NEW YORK (360Dx) – Diagnostics firm Quotient said after the close of the market on Tuesday that it has raised $64.6 million in net proceeds from a public offering of its ordinary shares.

The Switzerland-based firm said that it offered 10.6 million shares of its stock at $6.50 per share. The offering's underwriters exercised in full their option to purchase up to almost 1.4 million additional ordinary shares.

Jefferies and Cowen and Company acted as joint book-running managers for the offering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.